Diseases [C] » Digestive System Diseases [C06] » Liver Diseases » Chemical and Drug Induced Liver Injury
Diseases [C] » Chemically-Induced Disorders [C25] » Drug-Related Side Effects and Adverse Reactions » Chemical and Drug Induced Liver Injury
Diseases [C] » Chemically-Induced Disorders [C25] » Poisoning » Chemical and Drug Induced Liver Injury
Description
A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment. MeSH
Hierarchy View
Subtype Terms (2)
Approved Indicated Drugs (1)
Phase 3 Indicated Drugs (3)
Phase 2 Indicated Drugs (6)
Other Experimental Indicated Drugs (14)
Organization Involved with Phase 4 Indications (9)
Organization Involved with Phase 3 Indications (7)
Organization Involved with Phase 2 Indications (3)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (3)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.